Discovery of metabolically stabilized electronegative polyacridine-PEG peptide DNA open polyplexes

Area of Science:

• Biotechnology
• Molecular Biology
• Gene Therapy

Background:

• Cationic peptides and polymers form polyplexes with DNA via electrostatic interactions for in vitro gene transfection.
• Achieving efficient in vivo gene transfer remains a significant challenge for most cationic polyplexes.

Purpose of the Study:

• To develop and evaluate novel polyacridine PEG-peptides for gene delivery.
• To investigate their DNA binding mechanism and in vivo gene transfer capabilities.

Main Methods:

• Synthesis of polyacridine PEG-peptides by conjugating acridine derivatives to lysine residues in PEG-Cys-Trp-(Lys) peptides.
• Characterization of polyplexes using zeta potential and atomic force microscopy to assess charge and structure.
• Evaluation of DNA binding affinity, DNase protection, and in vivo gene transfer efficacy in mice via intramuscular injection and electroporation.

Main Results:

• Polyacridine PEG-peptides bind DNA through polyintercalation, forming electronegative, open polyplexes, distinct from traditional electrostatic polyplexes.
• PEG-Cys-Trp-(Lys-(Acr))(5) demonstrated superior DNA binding affinity and enhanced DNA protection against DNase.
• Successful in vivo gene transfer was achieved in mice using these polyacridine PEG-peptide DNA open polyplexes.

Conclusions:

• Polyacridine PEG-peptide DNA open polyplexes represent a novel approach for gene delivery.
• This method overcomes limitations of traditional cationic polyplexes for in vivo applications.
• The findings support the potential of polyacridine PEG-peptides as a viable in vivo gene delivery system.